- Impax Laboratories, Inc. stock price today and history
Impax Laboratories, Inc. (IPXL) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Impax Laboratories, Inc. stock price
Impax Laboratories, Inc. latest news:
Impax Labs shares rise on FDA approval of generic Renvela
Impax Laboratories Inc. shares rose in the extended session Monday after the drug maker said the Food and Drug Administration approved its generic version of Sanofi SA's Renvela. Impax shares advanced 5.7% to $21.50 after hours. The company said sales of the sevelamer carbonate, the generic name for Renvela, are reflected in its earnings outlook of 55 cents to 70 cents a share this year. Analysts surveyed by FactSet expect earnings of 70 cents a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
UnitedHealth and Morgan Stanley climb while Impax skids
UnitedHealth and Morgan Stanley advance while Impax Laboratories and Boeing slide
Imprimis Pharmaceuticals, Inc.IMMY
INC Research Holdings, Inc.INCR
Independent Bank Corp.INDB
Independent Bank CorporationIBCP
Independent Bank Group, IncIBTX
Industrial Services of America, Inc.IDSA
Infinity Pharmaceuticals, Inc.INFI